Exchange: OTC·Updated 12:09 PM EDT

ZVSA ZyVersa Therapeutics Inc

$0.099
$0.001
(1.00%)
Today
EarningsSep 14
Mkt Cap$801,496.00
Vol14,517.00

About ZVSA

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases. The company was founded by Stephen C. Glover in 2014 and is headquartered in Lighthouse Point, FL.
49

Neutral Sentiment

How do you feel about ZVSA?

Advertisement|Remove ads.